Your browser doesn't support javascript.
loading
Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC.
Sun, Yige; Yang, Jie; Li, Yingbo; Luo, Jing; Sun, Jiemei; Li, Daoshuang; Wang, Yuchen; Wang, Kai; Yang, Lili; Wu, Lina; Sun, Xilin.
Affiliation
  • Sun Y; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Yang J; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Li Y; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Luo J; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Sun J; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Li D; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Wang Y; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Wang K; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Yang L; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Wu L; NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin, 150028, Heilongjiang, China.
  • Sun X; Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, Harbin, 150028, Heilongjiang, China.
Mol Cancer ; 21(1): 212, 2022 12 01.
Article in En | MEDLINE | ID: mdl-36457016
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Nanoparticles / Liver Neoplasms / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Nanoparticles / Liver Neoplasms / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: China